H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Immunology D-index 65 Citations 22,432 167 World Ranking 1344 National Ranking 691
Medicine D-index 88 Citations 31,672 328 World Ranking 6546 National Ranking 3616

Research.com Recognitions

Awards & Achievements

Member of the Association of American Physicians


What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Gene
  • Acquired immunodeficiency syndrome

John W. Mellors spends much of his time researching Virology, Immunology, Acquired immunodeficiency syndrome, Viral load and Viremia. The concepts of his Virology study are interwoven with issues in Reverse transcriptase and Genotype. John W. Mellors has included themes like Drug, MEDLINE and Antiretroviral therapy in his Immunology study.

His work deals with themes such as Viral disease, Clinical research, Drug resistance and Intensive care medicine, which intersect with Acquired immunodeficiency syndrome. His work is dedicated to discovering how Viral load, Internal medicine are connected with Gastroenterology, Reverse-transcriptase inhibitor and Oncology and other disciplines. The study incorporates disciplines such as RNA and In vivo in addition to Virus.

His most cited work include:

  • Plasma Viral Load and CD4+ Lymphocytes as Prognostic Markers of HIV-1 Infection (1843 citations)
  • Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy (1665 citations)
  • Antiretroviral drug resistance testing in adult HIV-1 infection: Recommendations of an international AIDS society-USA panel (713 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of study are Virology, Immunology, Internal medicine, Virus and Viral load. His biological study spans a wide range of topics, including RNA, Reverse transcriptase and Drug resistance. He focuses mostly in the field of Reverse transcriptase, narrowing it down to matters related to Molecular biology and, in some cases, RNase H.

His Immunology research is multidisciplinary, incorporating perspectives in Acquired immunodeficiency syndrome and Antiretroviral therapy. Efavirenz is closely connected to Reverse-transcriptase inhibitor in his research, which is encompassed under the umbrella topic of Internal medicine. His work in Zidovudine covers topics such as Lamivudine which are related to areas like Indinavir.

He most often published in these fields:

  • Virology (51.55%)
  • Immunology (28.09%)
  • Internal medicine (19.07%)

What were the highlights of his more recent work (between 2017-2021)?

  • Virology (51.55%)
  • Antiretroviral therapy (12.37%)
  • Internal medicine (19.07%)

In recent papers he was focusing on the following fields of study:

John W. Mellors mainly investigates Virology, Antiretroviral therapy, Internal medicine, Viremia and RNA. His Virology study focuses on Virus in particular. His Virus research integrates issues from T cell, Monoclonal antibody and Drug resistance.

His Antiretroviral therapy study combines topics from a wide range of disciplines, such as Proviral dna and Viral load. John W. Mellors has researched Internal medicine in several fields, including HIV drug resistance, Acquired immunodeficiency syndrome and Oncology. In his research on the topic of Cohort, Cytotoxic T cell is strongly related with Immunology.

Between 2017 and 2021, his most popular works were:

  • Recommendations for analytical antiretroviral treatment interruptions in HIV research trials—report of a consensus meeting (70 citations)
  • The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Posttreatment Controllers Identified From 14 Clinical Studies (61 citations)
  • Risks and benefits of dolutegravir-based antiretroviral drug regimens in sub-Saharan Africa: a modelling study. (42 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Gene
  • Virus

His primary scientific interests are in Virology, Antiretroviral therapy, Viral load, Virus and RNA. His Virology research includes themes of Antibody, Glycoprotein and Provirus. His Viral load study incorporates themes from Viral suppression, Regimen, Lamivudine, Emtricitabine and Pediatrics.

His research in Lamivudine tackles topics such as Raltegravir which are related to areas like Internal medicine. His Emtricitabine research focuses on subjects like Young adult, which are linked to Cohort, Immunology, Clinical trial and Acquired immunodeficiency syndrome. The Virus study combines topics in areas such as Peripheral blood mononuclear cell, Art initiation and Monoclonal antibody.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Plasma Viral Load and CD4+ Lymphocytes as Prognostic Markers of HIV-1 Infection

John W. Mellors;Alvaro Munoz;Janis V. Giorgi;Joseph B. Margolick.
Annals of Internal Medicine (1997)

2676 Citations

Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy

R M Gulick;J W Mellors;D Havlir;J J Eron.
The New England Journal of Medicine (1997)

2322 Citations

HIV sequence compendium 2002

Carla Kuiken;Brian Foley;Eric Freed;Beatrice Hahn.

877 Citations

Antiretroviral drug resistance testing in adult HIV-1 infection: Recommendations of an international AIDS society-USA panel

Martin S. Hirsch;Martin S. Hirsch;Françoise Brun-Vézinet;Richard T. D'Aquila;Scott M. Hammer.
JAMA (2000)

818 Citations

Antiretroviral drug resistance testing in adults with HIV infection: Implications for clinical management

Martin S. Hirsch;Brian Conway;Richard T. D'Aquila;Victoria A. Johnson.
JAMA (1998)

718 Citations

Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel.

Martin S. Hirsch;Françoise Brun-Vézinet;Bonaventura Clotet;Brian Conway.
Clinical Infectious Diseases (2003)

668 Citations

Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy

Sarah Palmer;Frank Maldarelli;Ann Wiegand;Barry Bernstein.
Proceedings of the National Academy of Sciences of the United States of America (2008)

654 Citations

Specific HIV integration sites are linked to clonal expansion and persistence of infected cells

F. Maldarelli;X. Wu;L. Su;F. R. Simonetti.
Science (2014)

636 Citations

Depletion of latent HIV-1 infection in vivo: a proof-of-concept study

Ginger Lehrman;Ian B Hogue;Sarah Palmer;Cheryl Jennings.
The Lancet (2005)

631 Citations

Antiretroviral Drug Resistance Testing in Adult HIV-1 Infection: 2008 Recommendations of an International AIDS Society-USA Panel

Martin S. Hirsch;Huldrych F. Günthard;Jonathan M. Schapiro;Françoise Brun Vézinet.
Clinical Infectious Diseases (2008)

622 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing John W. Mellors

Robert F. Siliciano

Robert F. Siliciano

Johns Hopkins University School of Medicine

Publications: 219

Steven G. Deeks

Steven G. Deeks

University of California, San Francisco

Publications: 207

Douglas D. Richman

Douglas D. Richman

University of California, San Diego

Publications: 178

Sharon R. Lewin

Sharon R. Lewin

University of Melbourne

Publications: 174

Bruce D. Walker

Bruce D. Walker

Harvard University

Publications: 171

Mark A. Wainberg

Mark A. Wainberg

McGill University

Publications: 126

Daniel R. Kuritzkes

Daniel R. Kuritzkes

Brigham and Women's Hospital

Publications: 120

Julio S. G. Montaner

Julio S. G. Montaner

University of British Columbia

Publications: 119

Joseph J. Eron

Joseph J. Eron

University of North Carolina at Chapel Hill

Publications: 117

Huldrych F. Günthard

Huldrych F. Günthard

University of Zurich

Publications: 112

Javier Martinez-Picado

Javier Martinez-Picado

University of Vic

Publications: 107

Kenneth A. Freedberg

Kenneth A. Freedberg

Harvard University

Publications: 102

David A. Cooper

David A. Cooper

Pfizer (United States)

Publications: 99

Andrew N. Phillips

Andrew N. Phillips

University College London

Publications: 93

Robert W. Shafer

Robert W. Shafer

Stanford University

Publications: 91

David M. Margolis

David M. Margolis

University of North Carolina at Chapel Hill

Publications: 84

Something went wrong. Please try again later.